A Modern Look at Paroxysmal Supraventricular Tachycardia (PSVT)

Description

Learning Objectives
Upon completion of this activity, you should be able to: 

Distinguish between the diverse clinical presentations of PSVT, ranging from asymptomatic occurrences to severe symptoms with a focus on understanding the impact of symptoms on the patient’s quality of life.
Utilize a comprehensive and guideline-driven diagnostic approach that incorporates a thorough history, physical exam, and electrocardiogram (ECG) monitoring including consumer wearable devices.
Evaluate existing and emerging treatment strategies for PSVT, including their efficacy, safety profiles, and impact on health care utilization and hospitalizations.
Discuss the importance of the multi-disciplinary professional healthcare team in providing the PSVT patient with educational resources and supporting shared decision-making discussion about treatment options.

Faculty

Bruce Sheldon Stambler, MD, FACC (Chair)
Piedmont Heart Institute
Disclosure
Consultant Fees/Honoraria: Boston Scientific (Arrhythmias & Clinical EP); Additional: Milestone Pharma Consultant (No compensation)

Charles V. Pollack, Jr., MA, MD, FACEP, FAHA, FACC, FESC (Faculty)
University of Mississippi School of Medicine
Disclosure
Consultant Fees/Honoraria: Milestone Pharmaceuticals (Arrhythmias & Clinical EP); Data Safety Monitoring Board: Takeda Pharmaceuticals North America, Inc. (Vascular Medicine)

Target Audience  
The target audience for the clinician-facing educational activities are general cardiologists, electrophysiologists, and the cardiac care team (RN, NP, PA, ER staff).

Important Dates 
Date of Release: June 30, 2026
Term of Approval/Date of Expiration: June 30, 2027

Acknowledgement
Educational support for this activity provided by Milestone Pharmaceuticals Inc.

Summary

Availability:

On-Demand

Access expires on Jun 30, 2027

Cost:

FREE

Credit Offered:

No Credit Offered